Business Context and Reporting Period
This Form 8-K Current Report was filed by Angi Inc. on November 13, 2023. The filing discloses a significant executive appointment and the terms of a related employment agreement.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and employment terms.
Material Changes
On November 13, 2023, Angi Inc. appointed Jeffrey W. Kip as President. In this role, Mr. Kip will oversee finance, sales, marketing, and human resources functions while continuing to serve as Chief Executive Officer of Angi International. He will report to Chairman and CEO Joseph Levin.
Management Commentary and Compensation Terms
- Base Salary: $600,000 annually.
- Equity Grant: 2,200,000 restricted stock units (RSUs) vesting in four equal annual installments.
- Contract Term: One year with automatic renewals for successive one-year terms unless terminated with 90 days' notice.
- Severance: In the event of a "Qualifying Termination" (termination without cause, resignation for good reason, or non-renewal), Mr. Kip is eligible for one year of base salary and accelerated vesting of equity awards that would have vested during the severance period.
- Restrictions: Includes a non-compete covenant during employment and the severance period, and non-solicitation covenants for 18 months post-termination.
Investor Verification Checklist
- Verify the total equity value of the 2,200,000 RSUs based on the current market price of Angi Class A Common Stock.
- Review the full Employment Agreement (Exhibit 10.1) for specific definitions of "cause" and "good reason."
- Confirm the impact of this appointment on the existing leadership structure and reporting lines.
- Assess the potential dilution impact of the new equity grant on existing shareholders.